Ligand Pharmaceuticals Inc. (LGND)
Market Closed
3 Jun, 20:00
$
234. 40
+1.64
+0.7%
$
4.73B Market Cap
23.93 P/E Ratio
- Div Yield
154,380 Volume
4.45 Eps
$ 232.76
Previous Close 
Want to track LGND and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 1.96 | - |
| | | 1.49 | 2.02 |
| | | 1.93 | 3.09 |
| | | 1.43 | - |
| | | 0.78 | 1.33 |
| | | 1.19 | 1.27 |
| | | 1.34 | - |
| | | 1.06 | 1.4 |
| | | 0.78 | 1.2 |
| | | 0.66 | - |
| | | 0.61 | 1.02 |
| | | 0.59 | 0.62 |
| | | 0.4 | 0.5 |
| | | 0.67 | 0.97 |
| | | 0.65 | 0.66 |
| | | 0.42 | 0.56 |
| | | 0.4 | 0.49 |
| | | 0.27 | 0.33 |
| | | 0.6 | 0.6 |
| | | 0.31 | 0.36 |
| | | 0.14 | 0.24 |
| | | 0.25 | 0.35 |
| | | 0.19 | 0.28 |
| | | 0.07 | 0.12 |
| | | 0.05 | 0.07 |
| | | 0.09 | 0.16 |
| | | 0.21 | 0.19 |
LGND Earnings Reports FAQ
What is the earnings per share (EPS) for LGND?
The current EPS is 4.45.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately 19.94%, reflecting the LGND's performance and NASDAQ (NMS) market conditions.
When is the next earnings release date?
Ligand Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Ligand Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for LGND at this time, as Ligand Pharmaceuticals Inc has no recent EPS data to calculate it.
